activins has been researched along with Carcinoma, Ductal, Breast in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berman, H; Fessenden, T; Fordyce, C; Jung, J; Pickering, C; Singla, V; Tlsty, T | 1 |
Ay, AS; Bartholin, L; Goddard-Léon, S; Joguet, S; Razanajaona, D; Rimokh, R; Treilleux, I | 1 |
Büchler, MW; Friess, H; Ishiwata, T; Kleeff, J; Korc, M | 1 |
3 other study(ies) available for activins and Carcinoma, Ductal, Breast
Article | Year |
---|---|
DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
Topics: Activins; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p16; Cyclooxygenase 2; DNA Damage; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Gene Expression Profiling; Humans; Immunohistochemistry; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Precancerous Conditions; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Telomere; Telomeric Repeat Binding Protein 2; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2010 |
Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth.
Topics: Activins; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Follistatin; Follistatin-Related Proteins; Gene Silencing; Humans; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Smad2 Protein; Transfection; Transforming Growth Factor beta1; Tumor Cells, Cultured | 2007 |
Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Topics: Activin Receptors; Activins; Adolescent; Adult; Aged; Aged, 80 and over; Blotting, Northern; Carcinoma, Ductal, Breast; Cell Differentiation; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; In Vitro Techniques; Inhibins; Male; Middle Aged; Pancreatic Neoplasms; Polymerase Chain Reaction; Receptors, Growth Factor; Receptors, Peptide; Tumor Cells, Cultured; Up-Regulation | 1998 |